FDA official logo
GSRS logoPFDA official logo

ALPROSTADIL

UNII:F5TD010360
Type:INGREDIENT SUBSTANCE
Formula:C20H34O5
Preferred Substance Name:ALPROSTADIL
InChIKey:
GSRS Full Record:

  • 745-65-3
  • (-)-Prostaglandin E1
  • (11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid
  • (1R,2R,3R)-3-Hydroxy-2-[(E)-(3S)-3-hydroxy-1-octenyl]-5-oxocyclopentaneheptanoic acid
  • 11α,15(S)-Dihydroxy-9-oxo-13-trans-prostenoic acid
  • 11α,15α-Dihydroxy-9-oxo-13-trans-prostenoic acid
  • 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
  • ALPROSTADIL A-CYCLODEXTRIN
  • ALPROSTADIL ALFADEX
  • ALPROSTADIL ALFADEX [JAN]
  • ALPROSTADIL [JAN]
  • ALPROSTADIL [MART.]
  • ALPROSTADIL [ORANGE BOOK]
  • ALPROSTADIL [USAN]
  • ALPROSTADIL [USP IMPURITY]
  • ALPROSTADIL [USP MONOGRAPH]
  • ALPROSTADIL [USP-RS]
  • ALPROSTADIL [VANDF]
  • Alprostadil
  • Alprostadil [EP MONOGRAPH]
  • Alprostadil [WHO-DD]
  • Alprostadil alfadex [WHO-DD]
  • Alprostan
  • Alprox TD
  • Caveject
  • Caverject
  • Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)-
  • Cyclopentaneheptanoic acid, 3α-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-
  • Edex
  • Eglandin
  • Liple
  • Lipo PGE1
  • Lipoprost
  • Liprostin
  • Minprog
  • NSC 165559
  • ONO 1608
  • PROST-13-EN-1-OIC ACID, 11,15-DIHYDROXY-9-OXO-, (11A,13E,15S)-
  • PROSTAGLANDIN E1 [MI]
  • Palux
  • Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11α,13E,15S)-
  • Prostaglandin E1
  • Prostandin
  • Prostandin 500
  • Prostin VR Pediatric
  • Prostivas
  • SEPA-PGE1
  • SEPA-alprostadil
  • SEPA-prostaglandin E1
  • Topiglan
  • U 10136
  • U-10136
  • Vasaprostan
  • alprostadil [INN]
  • l-PGE1
  • l-Prostaglandin E1



UNII - F5TD010360 | UNII Search Service